MK-434
id:
mk-434-313-17816585
title:
MK-434
text:
MK-434 is a 5α-reductase inhibitor which was under development in the 1990s by Merck & Co for the treatment of a variety of androgen-dependent conditions including benign prostatic hyperplasia, prostate cancer, pattern hair loss, excessive hair growth, acne, and seborrhea but was never marketed. It acts as a selective inhibitor of 5α-reductase type 2. The drug has been found to decrease circulating dihydrotestosterone levels by a maximum of approximately 50% in men. MK-434 is a synthetic 4-azast
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/MK-434
date created:
date modified:
2022-03-14T00:30:27Z
main entity:
{"identifier":"Q55085966","url":"https://www.wikidata.org/entity/Q55085966"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/9/92/MK-434.svg","width":700,"height":485}
fields total:
13
integrity:
15